Epigenetic Targets in Drug Discovery

Wolfgang Sippl (Editor), Manfred Jung (Editor), Raimund Mannhold (Series Editor), Hugo Kubinyi (Series Editor), Gerd Folkers (Series Editor)

ISBN: 978-3-527-32355-5

Hardcover

314 pages

August 2009

List Price:	US $215.00
Government Price:	US $124.12
Enter Quantity: Buy

Epigenetic Targets in Drug Discovery (3527323554) cover image

< >

Fueled by the expertise of a team of international specialist authors, this first reference on the booming topic covers everything a drug researcher needs to know about targeting epigenetic mechanisms of disease.
The first part of the book surveys current methodologies for finding and validating drug candidates that act via epigenetic mechanisms. The second part systematically surveys known and suspected drug targets within the epigenetic machinery, including the discovery and development of vorinostat, the first marketed epigenetic drug.

Related Titles

More From This Series

Virtual Screening: Principles, Challenges, and Practical Guidelines

by Christoph Sotriffer (Editor), Raimund Mannhold (Series Editor), Hugo Kubinyi (Series Editor), Gerd Folkers (Series Editor)

Prodrugs and Targeted Delivery: Towards Better ADME Properties

by Jarkko Rautio (Editor), Raimund Mannhold (Series Editor), Hugo Kubinyi (Series Editor), Gerd Folkers (Series Editor)

Chemokine Receptors as Drug Targets

by Martine J. Smit (Editor), Sergio A. Lira (Editor), Rob Leurs (Editor), Raimund Mannhold (Series Editor), Hugo Kubinyi (Series Editor), Gerd Folkers (Series Editor)

Aspartic Acid Proteases as Therapeutic Targets

by Arun K. Ghosh (Editor), Raimund Mannhold (Series Editor), Hugo Kubinyi (Series Editor), Gerd Folkers (Series Editor)

Transporters as Drug Carriers: Structure, Function, Substrates

by Gerhard F. Ecker (Editor), Peter Chiba (Editor), Raimund Mannhold (Series Editor), Hugo Kubinyi (Series Editor), Gerd Folkers (Series Editor)